AssetMark Inc’s ChemoCentryx, Inc. CCXI Stock Holding History

AssetMark Inc’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,432	Closed	-$74K	–	1683
2022 Q3	$74K	Sell	1,432 -328	-19%	-$13.6K	﹤0.01%	886
2022 Q2	$44K	Buy	1,760 +1,378	+361%	+$30.4K	﹤0.01%	949
2022 Q1	$10K	Buy	382 +267	+232%	+$7.5K	﹤0.01%	1200
2021 Q4	$4K	Buy	+115	New	+$4.04K	﹤0.01%	1296
2021 Q2	–	Sell	-35	Closed	-$2K	–	1588
2021 Q1	$2K	Buy	35 +7	+25%	+$421	﹤0.01%	1214
2020 Q4	$2K	Hold	28	–	–	﹤0.01%	1260
2020 Q3	$2K	Buy	28 +2	+8%	+$108	﹤0.01%	1175
2020 Q2	$1K	Sell	26 -8	-24%	-$435	﹤0.01%	1228
2020 Q1	$1K	Buy	+34	New	+$1.44K	﹤0.01%	1318
2019 Q3	–	Sell	-54	Closed	-$1K	–	1464
2019 Q2	$1K	Buy	54 +16	+42%	+$185	﹤0.01%	1308
2019 Q1	$1K	Buy	+38	New	+$435	﹤0.01%	1307

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AssetMark Inc's CCXI Position: Q4 2022 in Review

AssetMark Inc sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,432 shares — an estimated $74K sold.

AssetMark Inc first reported a position in CCXI in Q1 2019 and held it in 11 quarters. The position peaked at $74K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

AssetMark Inc reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
AssetMark Inc sold 1,432 ChemoCentryx, Inc. shares in Q4 2022, an estimated $74K.
AssetMark Inc first reported a position in ChemoCentryx, Inc. in Q1 2019 and held it in 11 quarters.
AssetMark Inc's ChemoCentryx, Inc. position peaked at $74K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on AssetMark Inc's 13F filing for Q4 2022, filed 10 Feb 2023.